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Vibrio parahaemolyticus is a recognized enteropathogen causing diarrhea in humans and is
one of the major causes of seafoodborne gastroenteritis. An important virulence factor is
thermostable direct hemolysin (TDH), a pore-forming toxin, which is able to lyse
eukaryotic cells. The active toxin is a tetramer of four identical protein subunits, which is
secreted by the pathogen after cleavage of a signal peptide.
To establish diagnostic detection systems for TDH we expressed the hemolysin with and
without the signal peptide in a prokaryotic cell-free system to obtain pure toxin. In order
to purify and to facilitate the isolation from cell lysates we synthesized TDH variants with
different tags. Important regulatory sequences for cell-free protein synthesis as well as
sequences for N-terminal Strep-tag and C-terminal 6xHis-tag were added by a two-step
PCR. For the expression in the cell-free system these linear tdh templates were sub-
jected directly to prokaryotic cell extracts. Protein yields were in the range of 500–600 mg/
ml for the preproteins and approx. 300–400 mg/ml for the mature proteins. The identities
of expressed proteins were further conﬁrmed by SDS-PAGE, immunological and MALDI-
TOF mass spectrometric analyses. The functionality of newly synthesized toxin variants
was tested by performing qualitative and semiquantitative hemolysis assays. Cell-free
produced mature TDH and its variants were active while the preprotein and its de-
rivatives lacked hemolytic activity. A C-terminal 6xHis-tag showed less inﬂuence on
functionality compared to the N-terminal Strep-tag.
 2013 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
The simple and cost-effective preparation of proteins is
an essential prerequisite for initial studies to be made toC-ND license (http://
Biomedical Engineer-
g 13, 14476 Potsdam,
187 119.
e (S. Kubick).
ernal Medicine, Uni-
s. Published by Elsevier Ltd.clarify the molecular mechanisms of action for many
toxins. In this context, cell-free protein synthesis has
emerged as a powerful technology platform to overcome
the limitations of cellular systems for the synthesis and
functional characterization of proteinogenic toxins (Orth
et al., 2011). The characterization of bacterial pore-
forming proteins in particular, is often hampered by their
potent toxicity, which prevents their expression as a re-
combinant protein in living cells. Such pore-forming toxins
are major virulence factors of Vibrio parahaemolyticus, a
halophilic bacterium inhabiting marine environments
worldwide. Seafood contaminated with V. parahaemolyticus
can cause diarrheal diseases in humans after ingestion ofAll rights reserved.
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cause of diarrheal diseases worldwide, most common in
Asia and the United States of America (Anonymous, 2011).
Most clinical strains of V. parahaemolyticus show b-hemo-
lysis of human erythrocytes on a special blood agar
(Wagatsuma agar) designated as Kanagawa phenomenon
(KP) (Taniguchi et al., 1985). The KP is caused by a secreted
hemolysin which has been termed thermostable direct
hemolysin (TDH) because of its physicochemical properties
(Fukui et al., 2005). Strains harboring tdh genes and/or
genes encoding a TDH related hemolysin (TRH) are desig-
nated to be pathogenic, while V. parahaemolyticus lacking
these genes are regarded as non-pathogenic (Nishibuchi
and Kaper, 1995; Anonymous, 2011). Biochemical and bio-
logical studies have shown that TDH is the major virulence
factor of V. parahaemolyticus with multiple biological ac-
tivities including hemolysis, enterotoxicity, cardiotoxicity
and cytotoxicity (Nair et al., 2007).
TDH is a tetrameric toxin composed of four identical
protein subunits and forms pores in eukaryotic cell mem-
branes (Hamada et al., 2007). Genetic analysis revealed that
tdh genes show slight differences in various strains of V.
parahaemolyticus (Baba et al., 1992), however, the identity
of the TDH protein subunits among all different strains is
above 97%. All tdh genes encode a preprotein of 189 amino
acids (aa), which is secreted through the bacterial cell wall
by removing a signal peptide of 24 aa at the N-terminal end.
Finally, four soluble mature monomers assemble into the
active toxin forming a central pore through which small
molecules, e.g. water and ions, can freely diffuse
(Yanagihara et al., 2010). It has been reported that the
tetrameric toxin causes a colloidal osmotic lysis of eryth-
rocytes as a result of membrane permeabilization (Fabbri
et al., 1999). However, the exact mechanism of TDH
induced hemolysis is still unknown and further in-
vestigations are needed to clarify how TDH attaches to the
eukaryotic cell membrane of the host and induces pore
formation.
The rapid spread of a new pandemic strain of V. para-
haemolyticus O3:K6 throughout the world has increased
fears that the pathogen may contaminate also seafood
produced in European countries where V. parahaemolyticus
was rarely found to cause diarrheal diseases (Nair et al.,
2007). Some recent reports from Italy, Spain, France and
UK conﬁrmed that the O3:K6 clone has reached European
coastal regions (Ottaviani et al., 2008; Martinez-Urtaza
et al., 2005; Quilici et al., 2005; Powell et al., 2013) and
caused diarrheal diseases from locally produced mussels
(Ottaviani et al., 2008). In O3:K6 strains two tdh genes,
termed tdh1 and tdh2, are present. The tdh2 gene is strongly
expressed and is responsible for the Kanagawa phenotype
of pandemic strains (Nishibuchi and Kaper, 1995; Okuda
and Nishibuchi, 1998).
As TDH is a crucial virulence factor of pathogenic
strains of V. parahaemolyticus it is of interest to investigate
the production and occurrence of the toxin under
different conditions, e.g. in living organisms or food
matrices. Expression analysis of the tdh genes in recom-
binant Escherichia coli strains has been demonstrated,
however, the toxin was poorly secreted into the medium
and remained mostly within the cell lysates (Nishibuchiand Kaper, 1985; Iida and Yamamoto, 1990). To obtain
puriﬁed toxin for functional studies, generation of anti-
bodies, and for use as reference materials we expressed
the toxin in cell-free systems using lysates prepared from
E. coli cells. This technique can circumvent inhibitory ef-
fects on the producing microorganism associated with the
toxic potential of proteins or protein insolubility and in-
clusion body formation in the host cell (Zhao et al., 2011;
Yoh, 1991).2. Methods
2.1. Materials
Bacterial strains: V. parahaemolyticus O3:K6 strain
PMA1.6 isolated from foodborne outbreaks in Chile
(Fuenzalida et al., 2007) was cultivated in Luria–Bertani
(Sambrook and Russell, 2001) broth at 37 C under shaking
conditions (200–225 rpm). E coli K12 DH5a harboring re-
combinant plasmid pJET2-TDH2 was grown in LB at 37 C
supplemented with 100 mg ml1 ampicillin.
Kits for template generation (EasyXpress linear tem-
plate Kit Plus) were purchased from Qiagen, Hilden, Ger-
many. A reverse passive latex agglutination test (KAP-RPLA
test) was obtained from Denka Seiken, Tokyo, Japan. All
other reagents were of analytical grade and commercially
available.2.2. Generation of DNA templates
TDH1 and TDH2 were expressed using either chromo-
somal DNA or the recombinant plasmid pJET2-TDH2 (see
below) as PCR templates. Generation of PCR products for
in vitro transcription/translation reactions was based on a
two-step Expression-PCR (E-PCR) procedure. Toxin encod-
ing DNA was ampliﬁed in the ﬁrst PCR step (E-PCR1) using
gene-speciﬁc primers listed in Table 1 (PCR-conditions:
10 Fermentas PCR-buffer, dNTPs 0.2 mM each, forward
and reverse primer 0.5 mM each, 0.05 U/ml Taq DNA poly-
merase, 2 ng DNA, ad MilliQ H2O to a ﬁnal volume of 50 ml.
Initial denaturation at 95 C for 10 min, denaturation at
94 C for 30 s, primer annealing at 54 C for 30 s, primer
extension at 72 C for 45 s, ﬁnal extension at 72 C for
5 min; number of cycles: 30) (Table 2).
100 ng PCR product from the ﬁrst PCR step was directly
applied to the second PCR ampliﬁcation (E-PCR2) proce-
dure. In E-PCR2 adapter primers were used to add tag-
encoding sequences and regulatory sequences at the 50-
and 30-end of the ﬁnal PCR-product for cell-free expression
(Suppl. Table S1). Ampliﬁcation was performed according
to the manufacturers recommendations (EasyXpress Linear
Template Kit PLUS, Qiagen, Hilden, Germany). E-PCR2 was
performed in a ﬁnal volume of 25 ml (PCR-conditions: 5 ml
5 High Fidelity PCR buffer, 2.5 ml adapter primer each,
High Fidelity DNA Polymerase 0.05 U/ml, initial denatur-
ation at 95 C for 5 min, denaturation at 94 C for 60 s,
primer annealing at 50 C for 60 s, primer extension at 72 C
for 45 s, ﬁnal extension at 72 C for 10 min; number of
cycles: 30).
Table 1
Primers used for construction of linear templates of ﬁrst E-PCR step E-PCR1. Bold letters indicate sequences from tdh2 gene.
Primer Primersequence 50 / 30
X-Vpara-preTDH-F AGA AGG AGA TAA ACA – ATG – AAG TAC CGA TAT TTT GC
X-Vpara-preTDH-SF AAA AGC GCT GAA AAC CTG ATC GAA GGC CGT – AAG TAC CGA TAT TTT GC
X-Vpara-mTDH-F AGA AGG AGA TAA ACA – ATG – TTT GAG CTT CCA TCT GT CCC
X-Vpara-mTDH-SF AAA AGC GCT GAA AAC CTG ATC GAA GGC CGT – TTT GAG CTT CCA TCT GT CCC
X-Vpara-TDH-R CTT GGT TAG TTA GTT A – TTA – TTG TTG ATG TTT ACA TTC AA
X-Vpara-TDH-HR TG GTG ATG GTG GTG ACC CCA – TTG TTG ATG TTT ACA TTC AA
Abbreviations: pre ¼ preprotein, m ¼ mature protein, SF ¼ extension sequence for N-terminal Strep-tag adapter primers, HR ¼ extension sequence for C-
terminal 6xHis-tag adapter primers.
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electrophoresis to determine quality and concentration by
comparison with a known DNA marker.
A 9 ml aliquot of the individual linear E-PCR2 products
was directly used in the cell-free prokaryotic system
without any further puriﬁcation.2.3. Cloning of the tdh2 gene in E. coli K12
Genomic DNA extraction from V. parahaemolyticus
O3:K6 strain was performed with the RTP Bacteria DNA Kit
from Stratec Molecular, Berlin, Germany. Primers used for
the ampliﬁcation of the tdh2 gene for the construction of an
E. coli recombinant plasmid were VparaF (50-CAA AGC CTC
ATA GAG TTG TAA G-30) and VparaR (50-GAA GCG AAT AAA
TAG CGT G-30) amplifying an 972 bp fragment of the
genomic DNA of the O3:K6 strain PMA1.6 containing the
complete coding sequence of the tdh2 gene (Suppl. Fig. S3).
PCR reaction was performed with DreamTaqTM DNA Po-
lymerase (Fermentas, St. Leon-Rot, Germany) according to
themanufacturers recommendations. The PCR product was
inserted into the multiple cloning site of the vector pJET2
(Fermentas, St. Leon-Rot, Germany). Finally, the plasmid
pJET2-TDH2 was introduced into E. coli DH5a. Sequencing
of plasmids and PCR products was carried out by QIAGEN
sequencing services (Hilden, Germany). The obtained se-
quences were analyzed using the Lasergene program
“SeqMan” (DNASTAR, Inc., Madison, USA). Sequence
translations were performed using the program Accelrys
(DS-) gene (Accelrys Inc., San Diego, USA). The plasmid
containing the tdh2 gene with the correct orientation andTable 2
Construction overview of the E-PCR products.
Name of gene Ampliﬁed gene E-PCR1
Primer forwar
preTDH preTDH2 X-Vpara-preTD
preTDH-His preTDH2-His X-Vpara-preTD
Strep-preTDH Strep-preTDH2 X-Vpara-preTD
Strep-preTDH-His Strep-preTDH2-His X-Vpara-preTD
mTDH mTDH1 and mTDH2 X-Vpara-mTDH
mTDH-His mTDH1-His and mTDH2-His X-Vpara-mTDH
Strep-mTDH Strep-mTDH1 and Strep-mTDH2 X-Vpara-mTDH
Strep-mTDH-His Strep-mTDH1-His and Strep-mTDH2-His X-Vpara-mTDH
Abbreviations: pre ¼ preprotein, m ¼ mature protein, SF ¼ extension sequence
terminal 6x-His tag adapter primers, S ¼ Sense primer, AS ¼ Antisense primer.coding sequence was ﬁnally used as a template for E-PCR1
reactions.
2.4. In vitro transcription and translation in E. coli lysates
Proteins were expressed in cell-free systems using E-
PCR2 products as template with E. coli lysates which were
prepared as described before (Broedel et al., 2013). A typical
50 ml standard reaction comprised 35% (v/v) E. coli lysate
containing T7 RNA-polymerase, 40% reaction buffer con-
taining complete amino acids (1.2 mM each), 25 XE-
solution (EasyXpress linear template Kit Plus, Qiagen),
9 ml linear E-PCR2 product and 14C-labeled leucine (Perkin
Elmer, Leucine, L-[14C(U)], ﬁnal concentration: 50 mM; 4
DPM/pmol). Coupled transcription-translation reactions
were performed in a thermomixer (37 C, 500 rpm) for
90 min, followed by a detailed analysis described in 2.5. To
determine the toxin’s integrity and functionality an aliquot
of a nonradioactive crude reaction mixture (CRM) and the
supernatant (SN) was analyzed by hemolysis and RPLA
agglutination assays. Hemolytic activity of cell-free syn-
thesized toxins was determined as described below.
2.5. Analysis of 14C-labeled proteins
The total yield and soluble protein was determined by
hot trichloroacetic acid (TCA)-precipitation. Total protein
yield was determined from CRM and soluble protein in the
supernatant (SN) which was obtained after a 10 min
centrifugation step at 16,000 g at room temperature. After
synthesis, 5 ml aliquots of the translation reactions (CRM
and SN) were stopped by the addition of 3 ml TCA (10%E-PCR2
d Primer reverse Primer forward Primer reverse Product
size [bp]
H-F X-Vpara-TDH-R No tag-S No tag-AS 794
H-F X-Vpara-TDH-HR No tag-S His tag-AS 822
H-SF X-Vpara-TDH-R Strep tag-S No tag-AS 863
H-SF X-Vpara-TDH-HR Strep tag-S His tag-AS 891
-F X-Vpara-TDH-R No tag-S No tag-AS 728
-F X-Vpara-TDH-HR No tag-S His tag-AS 756
-SF X-Vpara-TDH-R Strep tag-S No tag-AS 797
-SF X-Vpara-TDH-HR Strep tag-S His tag-AS 825
for N-terminal Strep-tag adapter primers, HR ¼ extension sequence for C-
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synthesized proteins and to hydrolyze the amino acids on
charged tRNAs, samples containing TCA were placed in
boiling water for 15 min and then cooled in ice for 30 min.
TCA-precipitated proteins were collected on ﬁlters (Mach-
ery-Nagel, MN GF-3). Protein loaded ﬁlters were washed
twice with TCA (5% solution w/o casein hydrolysate) and
rinsed twice with acetone. Dry ﬁlters were placed in scin-
tillation vials and subsequently 3 ml scintillation cocktail
(Zinsser Analytic, Quicksafe A) was added. Radioactivity
was measured and zero-time blank was subtracted from
radioactive samples (Beckmann Coulter, LS 6500 Multi
Purpose Scintillation Counter).
To determine the homogeneity and size of in vitro
translated proteins, 5 ml aliquots of radioactively labeled
cell-free synthesis reactions (CRM and SN) were diluted in
water (1:10) 0.150 ml ice-cold acetonewas added andprobes
were incubated on ice for 15min. Sampleswere centrifuged
at 16,000 g for 5 min at 4 C. The protein pellet was
resuspended in 20 ml sample buffer (Life technologies, LDS-
sample buffer) and subjected under reducing conditions to
10% Bis-Tris NuPAGE Novex gel (Life technologies). Subse-
quently, the gel was dried for 1 h and exposed to storage
phosphor screens (GE Healthcare, Mounted GP) for 24 h.
Radioactively labeled proteins were visualized using a
phosphor-imager (Typhoon Trioþ, GE Healthcare).
2.6. Puriﬁcation of His-tagged TDH and protein identiﬁcation
using MALDI-TOF MS
Puriﬁcation of His-tagged TDH proteins was performed
using the Dynabeads-His-tag Isolation and Pulldown Kit
according to the manufacturer’s recommendation (Invi-
trogen, Darmstadt, Germany). After SDS-PAGE (10%) pro-
teins were transferred onto Nitrocellulose membrane
(Biorad). Proteins were detected using Universal His
Western Blot Kit 2.0 (Clontech) according to the manufac-
tures protocol.
For mass spectrometric protein identiﬁcation TDH-
bands were excised from Coomassie blue stained SDS
gels, destained with 50% acetonitrile: 50 mM ammonium
bicarbonate and the gel was dehydrated by the addition of
enough 100% acetonitrile to cover each gel piece. Finally,
the samples were dried in a Speed-Vac for 5 min. The
sample was rehydrated with 10 mM DTT, incubated for
45 min at 56 C and then alkylated with 54 mM iodoa-
cetamide: 25 mM ammonium bicarbonate for 30 min at
room temperature in the dark. Samples were washed two
times in 10 mM ammonium bicarbonate followed by in-
cubation in 10 mM ammonium bicarbonate: 50% aceto-
nitrile. After the ﬁnal dehydration the sample was dried in
a Speed-Vac. The gel bands were rehydrated (with a
12.5 ng/ml solution of trypsin) in ice cold 50 mM ammo-
nium bicarbonate and incubated on ice for 30 min. Gel
bands were covered by adding 50 mM ammonium bicar-
bonate, then placed at 37 C overnight. The trypsin
digestionwas stopped by the addition of 1% triﬂuoroacetic
acid: 30% acetonitrile. Samples were centrifuged and the
supernatants concentrated using ZipTip C18 pipette tips
according to the manufacturers instructions (Millipore,
Billerica, MA).Peptide extracts were mixed on the MALDI-TOF sam-
ple plate with matrix and dried. The matrix was a
concentrated solution of a-cyano-4-hydroxy-cinnamic
acid in 1% triﬂuoroacetic acid: 50% acetonitrile (Bruker
Daltonics, Bremen). MALDI TOF-MS was performed using
a Bruker Ultraﬂex II MALDI-TOF mass spectrometer
(Bruker Daltonics, Bremen). MALDI-MS/MS mass spectra
were acquired in LIFT mode. Database searches (NCBI),
through Mascot were performed via BioTools 3.0 soft-
ware (Bruker Daltonics) using PMF and MS/MS (PFF)
datasets.
2.7. Immunological detection of TDH
A reversed passive latex agglutination test (KAP-RPLA
test) was used for the detection of cell-free produced TDH
proteins (Denka Seiken, Tokyo, Japan). The KAP-RPLA
“Seiken” speciﬁcally detects V. parahaemolyticus TDH
with rabbit antisera. The test was performed according to
the manufacturer’s instructions. Brieﬂy, 5 ml of CRMs from
each in vitro transcription-translation reaction were
added to 95 ml of diluent reagent and serial twofold di-
lutions were made with 25 ml diluent reagent in microtiter
plates. Each suspension was tested in parallel with
sensitized latex and control latex (25 ml each, ﬁve dilutions
per series). The plates were incubated overnight at room
temperature.
2.8. Qualitative and semiquantitative hemolysis assay
In order to investigate the hemolytic activity of cell-
free synthesized TDH proteins, 10 ml aliquots of in vitro
translation reaction (CRM and SN) were directly spotted
on a blood agar plate. Toxin concentrations in superna-
tants were adjusted to a concentration of 120 mg/ml with
the SN of the no template control (NTC) reaction. Blood
agar plates were prepared from Columbia agar (Merck,
Darmstadt; 23 g peptone, 1 g starch, 5 g NaCl, 10 g Agar–
Agar; pH 7.2) and contained 4% pre-washed rabbit
erythrocytes in phosphate-buffered-saline. Rabbit eryth-
rocytes were prepared freshly from blood (not older than
24 h after bleeding). In case of human blood the number of
erythrocytes was adjusted to 3.2  107 cells/ml (Blood
donation service of the German Red Cross, Berlin-
Dahlem). To suppress microbial growth the medium
contained 100 mg/ml kanamycin. Zones of hemolysis were
visually determined after 20 h incubation at 37 C. Cell
lysis with detergent solution (1% Triton X) was used as a
positive control.
To quantify the hemolytic activity of cell-free synthe-
sized TDH proteins, aliquots of SN starting with 3 mg soluble
toxinwere mixed in a twofold serial dilutionwith 60 ml PBS
at each step. Finally, 60 ml PBS with 4% rabbit erythrocytes
was added to each serial dilution and the samples were
incubated for 1 h at 37 C. Cell debris was sedimented by
centrifugation at 400 x g for 5 min. As a measure of he-
molysis, the amount of heme present in the supernatant
was determined spectrophotometrically (measuring the
optical density, OD570). Extinction values were set in pro-
portion to the maximum loss of heme in the positive con-
trol (4% Triton X).
Fig. 2. PCR templates for TDH expression generated by E-PCR. An aliquot
(1 ml) of E-PCR2 product was analyzed on a 1% agarosegel, marker lane: M,
lane 1: Strep-preTDH, lane 2: Strep-mTDH, lane 3: preTDH-His, lane 4:
mTDH-His, lane 5: preTDH, lane 6: mTDH, lane 7: Strep-preTDH-His, lane 8:
Strep-mTDH-His.
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3.1. PCR-ampliﬁcation of tdh genes and their tagged variants
from genomic DNA of a pandemic V. parahaemolyticus O3:K6
strain
Genomic DNA of the pandemic V. parahaemolyticus
O3:K6 strain PMA1.6 (Fuenzalida et al., 2007) was used as
template for the generation of different TDH constructs.
Oligonucleotide primers for the E-PCR1 consisted of gene
speciﬁc sequences and sequences serving as adapters for
the E-PCR2 (see Table 1). All gene speciﬁc sequences were
derived from the coding sequence (cds) of the tdh2 gene.
The forward PCR-primers for ampliﬁcation of the complete
cds encoding preTDH2 harbored the sequence 50-AAG TAC
CGA TAT TTT GC-30 corresponding to the nucleotides
immediately after the start codon ATG, while forward PCR-
primers used for the ampliﬁcation of the mature toxin
derivatives contained the sequence 50-TTT GAG CTT CCA
TCT GT CCC-30 which is the 30 region downstream of a
sequence encoding the signal peptide that is cleaved off
during secretion. All reverse primers contained the
sequence 50-TTG TTG ATG TTT ACA TTC AA-30 which is the
sequence upstream of the stop codon (see Suppl. Fig. S1).
The pandemic strain PMA1.6 gene harbors two very closely
related tdh genes of identical length (tdh1 and tdh2) and the
forward primers with gene speciﬁc sequences for the
mature toxin and the reverse primers anneal to both genes.
The forward primers harboring sequences encoding the
signal peptide of the preprotein anneal only to the tdh2
gene. Therefore, PCR products for the mature toxin contain
the cds of tdh1 and tdh2, while the PCR product of the
preprotein encodes only TDH2.
To enable fast puriﬁcation of toxins sequences encoding
6xHis-tag and Strep-tag together with regulatory se-
quences were incorporated into the primers for E-PCR2
(see Suppl. Table S1). Fig. 1 gives an overview of the design
of eight different toxin variants used in the cell-free
expression system. The different templates encoded
either an N-terminal Strep-tag with a cleavage site forFig. 1. Schematic drawing of TDH variants generated by cell-free expression. *
Strep ¼ Strep-tag, His ¼ 6xHis-tag, pre ¼ preprotein, m ¼ mature protein, N ¼ N-tprotease factor Xa, a C-terminal 6xHis-tag, both tags (N-
terminal Strep-tag and C-terminal 6xHis-tag) or no tag at
all. All PCR products with the expected sizes were produced
with the same efﬁciency (Fig. 2).
3.2. Cell-free synthesis of TDH proteins
Toxin variants were synthesized in a prokaryotic in vitro
transcription-translation system with lysates from E. coli.
Prokaryotic cell-free protein synthesis provides highindicates cleavage site for Factor Xa. Abbreviations: SP ¼ signal peptide,
erminus, C ¼ C-terminus.
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et al., 2013). The rate of toxin synthesis in the prokaryotic
system was determined by incorporation of 14C-labeled
leucine into TDH proteins. Aliquots of the crude reaction
mixtures (CRMs) and supernatants (SNs) were analyzed for
homogeneity and size using SDS-PAGE followed by auto-
radiography (Fig. 3).
As expected in case of the preprotein and its tagged
derivatives only one radioactively labeled protein was
synthesized in the E. coli lysates (Fig. 3A lanes 1, 3, 5, and 7),
while in case of the mature toxin and its tagged derivatives
two protein bands are visible in all lanes (see Fig. 3B). These
proteins (mTDH1 and mTDH2) differ in 7 amino acids in
their primary sequence, thereby resulting in a different
migration in the SDS page. The range of molecular weights
of the synthesized proteins is between 20 and 25 kDa and
corresponds to the published data (Honda et al., 1988; Iida
and Yamamoto, 1990). All toxin variants derived from the
preprotein, are insoluble as centrifugation at 16,000 g for
10 min of the CRMs was leading to a more or less completeFig. 3. Synthesis of 14C labeled proteins. 5 ml aliquots of radiolabeled cell-free synth
(left); 14C labeled proteins were visualized after electrophoresis with a phosphorima
M ¼ Marker, lane 1 preTDH CRM, lane 2 preTDH SN, lane 3 preTDH-His CRM, lane
Strep-preTDH-His CRM, lane 8 Strep-preTDH-His SN, lane 9 no template control reac
1 mTDH CRM, lane 2 TDH SN, lane 3 mTDH-His CRM, lane 4 mTDH-His SN, lane 5 St
Strep-mTDH-His SN.loss of radioactivity in the remaining supernatant. In case of
the mature toxin and its tagged derivatives 40–60% of
radioactivity was measured in the supernatant.
The incorporation of 14C leucine into the CRM and the
SN was determined to quantify the total toxin yields and
the soluble toxin yields (Fig. 4). Synthesis rates in CRMs
were about 500 mg/ml for the preprotein and its derivatives
and around 300 mg/ml for the mature proteins and their
derivatives which is in the range of published data per-
forming cell-free synthesis with prokaryotic lysates in a
batch mode (Kim et al., 1996; Carlson et al., 2012). Only the
mature toxin variants were soluble, showing a protein yield
in supernatant of 40–50% compared to the total protein
yield in CRM. The insolubility of the preprotein likely was
an effect of the signal peptide that possesses a number of
lipophylic amino acid residues. Standard E. coli lysates are
unable to remove signal peptides from polypeptide chains.
The concentration of synthesized toxins in the cell-free
system was approximately 80 fold above the typical toxin
concentrations found in the cell supernatants of V.esis reactions (CRM and SN) were loaded on a 10% Bis-Tris NuPAGE Novex gel
ger system (Typhoon TRIOþ Imager, GE Healthcare) (right). [Top] Preproteins.
4 preTDH-His SN, lane 5 Strep-preTDH CRM, lane 6 Strep-preTDH SN, lane 7
tion (NTC) CRM, lane 10 NTC SN. [Bottom] Mature proteins. M ¼Marker, lane
rep-mTDH CRM, lane 6 Strep-mTDH SN, lane 7 Strep-mTDH-His CRM, lane 8
Fig. 4. Expression yield of TDH constructs in the prokaryotic cell free sys-
tem. Quantitative analysis of 14C-leucine-labeled protein was performed by
liquid scintillation counting after hot TCA precipitation. Total protein was
analyzed in CRM and soluble protein was analyzed in SN.
Fig. 5. Hemolytic activity of preTDH and mTDH proteins on rabbit eryth-
rocytes. 10 ml of CRMs with preTDH proteins and 10 ml of supernatants (SNs)
with mTDH toxins (adjusted to 120 mg/ml soluble toxin) were spotted on a
blood agar plate. (1) Strep-preTDH, (2) Strep-mTDH, (3) preTDH-His, (4)
mTDH-His, (5) preTDH, (6) mTDH, (7) Strep-preTDH-His, (8) Strep-mTDH-
His, (9) NTC CRM as a negative control, (10) 1% Triton X as a positive control.
S. Bechlars et al. / Toxicon 76 (2013) 132–142138parahaemolyticus which was reported to yield 2.2 mg/ml
(Nishibuchi et al., 1991) under optimized culture
conditions.
3.3. Immunological detection of TDH with KAP-RPLA
To conﬁrm the synthesis of TDH and its derivatives in
the cell-free system we used a commercial available kit
containing latex beads coated with polyclonal anti-TDH
rabbit antibodies (KAP-RPLA, Denka Seiken, Japan). CRMs
were diluted twofold according to the manufacturer’s
recommendation (see Material and Methods). While the
control CRM without template DNA did not show any
agglutination reaction at all, agglutination of anti-TDH
antibody coated beads was observed in all serial dilutions
of CRMs with TDH templates. All CRMs were tested in ﬁve
serial twofold dilutions (Table 3). In all CRMs de novo syn-
thesized proteins showed a positive agglutination reaction.
3.4. Evaluation of functionality by hemolysis
To test if functional toxins were synthesized in the cell-
free systems, their hemolytic activity was determined. ToTable 3
Immunological detection of TDH. 2.5 ml aliquots of CRMs with TDH variants we
antibody coated beads (KAP-RPLA test).
Construct Hemolytic activity
(see Fig. 5)
Ini
(mg
preTDH (þ) 1.2
mTDH þ 0.6
preTDH-His  1.2
mTDH-His þ 0.7
Strep-preTDH  1.2
Strep-mTDH þ 0.8
Strep-preTDH-His  1.4
Strep-mTDH-His þ 0.9
NTC (no template control reaction)  
Diluent  
þ positive, (þ) weak positive,  negative.
a Reciprocal value of agglutination titers with antisera (rabbit IgG against TDH
b No agglutination, lowest dilution.this end, aliquots of the CRMs and SNs were taken and
spotted directly on blood agar plates containing rabbit
erythrocytes. To quantify the hemolytic activity of the
mature proteins and their tagged derivatives aliquots of
supernatants (SNs) all SNs were adjusted to contain the
same amount of soluble toxins (120 mg/ml). After 20 h of
incubation at 37 C clear zones of hemolysis were visible on
the plates. The weakest hemolytic activity was observed in
case of the double tagged toxin (Strep- and 6xHis-tagged)
and the largest zone was caused by the untagged mTDH.
Neither the control CRM (no template control reaction,
NTC) nor the CRMs from tagged preprotein derivatives
produced visible hemolysis except preTDH2, where a very
small zone of hemolysis was visible (Fig. 5 spot 5).re tested using a reversed passive latex agglutination test with anti-TDH
tial protein content
in 2.5 ml)
Agglutination activity
Sensitized latexa Control latexb
1 >320 <20
8 >320 <20
6 >320 <20
5 >320 <20
8 >320 <20
2 >320 <20
5 >320 <20
2 >320 <20
<20 <20
<20 <20
).
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its different variants a semiquantitative hemolysis assay
was performed. Twofold serial dilutions taken from the SN
containing the soluble mature toxins and their tagged de-
rivatives were incubated with 4% rabbit erythrocytes. Lysis
of erythrocytes was determined photometrically and
conﬁrmed that the mature toxinwithout any additional tag
has the highest activity as it showed hemolysis in the
highest dilution containing 0.09 mg protein (Fig. 6). The C-
terminal His-tagged toxin was the derivative with the
second highest hemolytic activity, while the two other
toxin derivatives (Strep-mTDH and Strep-mTDH-His)
showed the weakest activity. Recent studies indicate that
tetramer formation is indispensable for hemolytic activity
(Yanagihara et al., 2010) which means that cell-free syn-
thesized TDH monomers are able to oligomerize to intact
and functional tetramers in solution. Further results sug-
gest that the adhesion of TDH to erythrocytes depends on
two processes: binding and post-binding (Tang et al., 1994).
Postbinding effects, which take place after binding to the
cell membrane and prior to lysis of the cell, are speciﬁed as
e.g. toxin oligomerization, permeabilization of the cell
membrane and insertion into the membrane. Also TDH
induced phosphorylation of speciﬁc membrane proteins
has been demonstrated to be important for hemolysis (Yoh
et al., 1996). While the N-terminus region may be involved
in binding, a region near the C-terminal may be responsible
for post-binding (Tang et al., 1997). Tagged termini might
inﬂuence binding and postbinding processes of TDH and
could be an explanation for the weaker hemolytic activity
of tagged proteins.
One disulﬁde bridge is formed in the subunits
(Tsunasawa et al., 1987; Nishibuchi et al., 1989), however,
the disulﬁde bond is possibly not important for hemolytic
activity of TDH (Baba et al., 1992; Yanagihara et al., 2010). It
has been shown that forming of disulﬁde bonds is generally
possible in a simple batch reaction of the E. coli based cell-
free protein synthesis system (Kim and Swartz, 2004).Hemolysis Assay
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Fig. 6. Semiquantitative hemolysis assay of supernatants (SNs) containing
mTDH and variants with rabbit erythrocytes. Twofold serial dilutions of
supernatant starting with 3 mg protein were mixed with 4% rabbit eryth-
rocytes in PBS. Samples were incubated for 1 h at 37 C followed by
centrifugation and photometric measurement of the released heme at
570 nm.3.5. Puriﬁcation and western blot detection of His-tagged
TDH derivatives and mass spectrometry
The addition of tags offers a great advantage for the
puriﬁcation of the toxin and its further application, there-
fore we decided to analyze the toxin variant synthesized
with an additional C-terminal His-tag more intensively.
His-tagged toxins were puriﬁed using His-tag
Dynabeads. Aliquots of CRMs and puriﬁed toxin de-
rivatives were loaded on SDS-PAGE and transferred to
nitrocellulose membrane after electrophoresis (Fig. 7). The
Western Blot revealed again that only one protein was
synthesized when the DNA construct encoding preTDH-His
(protein band I, Fig. 7B lane 1) was used as a template,
whereas from the PCR product encoding mTDH-His two
His-tagged proteins were produced (bands II and III in lane
2). This result was also visible after puriﬁcation with His-
tag Dynabeads (lanes 3 and 4). The puriﬁed His-tagged
mTDH displayed hemolytic activity as did the unpuriﬁed
TDH from the supernatant fraction (data not shown).
To conﬁrm the identities of the cell free expressed
TDH proteins, three protein bands were excised from
SDS-PAGE gels and subjected to tryptic in-gel digestion
followed by tandem MALDI-TOF mass spectrometry (MS/
MS) protein identiﬁcation. Protein database searches
for band I retrieved thermostable direct hemolysin
A (TDH2) of O3:K6 reference strain V. parahaemolyticus
RIMD 2210633. MALDI-TOF MS/MS spectrometry analysis
revealed two diagnostic peaks corresponding to
peptides DTTFNTNAPVNVEVSDFWTNR (m/z 2427.1) and
SDQVQLQHSYDSVANFVGEDEDSIPSK (m/z 2994.4) (see
Suppl. Fig. S2). The same peaks were found in band II.
Interestingly, the peak at m/z 2994.4 was missing in the
MS analysis of band III, but instead a peak at m/z 2877.6
was observed, which is diagnostic for thermostable direct
hemolysin S (TDH1) of V. parahaemolyticus from RIMD
2210633 and corresponds to peptide SGQVQLQHSYNS-
VANFVGEDEGSIPSK. This peptide contains three amino
acid exchanges compared to the corresponding sequence
in TDH2, which could be conﬁrmed by MALDI-TOF MS/
MS analyses. Thus we concluded that protein I corre-
sponded to the preprotein of TDH2 containing the signal
peptide, while proteins II and III were derived from the
chromosomal genes tdh1 and tdh2 lacking the sequence
encoding the signal peptide.
3.6. Cell free synthesis of TDH2 from a cloned tdh2 plasmid
template
As shown above, two proteins were synthesized when
primers containing gene speciﬁc sequences for the mature
toxins were used. Analysis of the Kanagawa phenomenon
has shown that the hemolytic activity of V. para-
haemolyticus strains containing tdh1 and tdh2 genes is
mainly caused by TDH2. The dominant expression of tdh2 is
due to differences in the promoter regions between the two
gene variants (Okuda and Nishibuchi, 1998). To study cell-
free expression of TDH2 separately, we therefore cloned
the tdh2 gene in an E. coli vector and used the resulting
recombinant plasmid pJET2-tdh2 as a template for the ﬁrst
step E-PCR1 ampliﬁcation of the coding sequence of
Fig. 7. SDS page and Western blot analysis of TDH constructs with C-terminal 6xHis-tag. [A] Aliquots (20 ml per lane) of CRMs were subjected to 13.5% SDS-PAGE
and [B] analyzed using Western blotting with a His-detection kit before and after puriﬁcation. Lane 1 preTDH-His, lane 2 mTDH-His, lane 3 puriﬁed preTDH-His,
lane 4 puriﬁed mTDH-His, lane 5 NTC CRM as a negative control. In lanes 1 and 3 the full length preTDH was synthesized (labeled I), while in lanes 2 and 4
mTDH1- and mTDH2-templates with His-tags were ampliﬁed simultaneously from the chromosomal DNA template prior to their co-expression in the E. coli cell-
free protein synthesis system (bands II and III). Protein bands I, II and III were analyzed by MALDI-TOF mass spectrometry.
S. Bechlars et al. / Toxicon 76 (2013) 132–142140preTDH and mTDH. As expected the cell-free synthesis
yielded only one protein band for the mature toxin (and the
preprotein). This was demonstrated by incorporation of 14C
labeled leucine (Fig. 8). The toxin synthesis rate in these
experiments was within the same range as the synthesis
rate with the chromosomal template. TCA precipitation
yielded toxin synthesis rates for the CRM containing
mature TDH2-His of approx. 300 mg/ml and in the super-
natant a concentration of approx. 150 mg/ml could beFig. 8. Synthesis of preTDH-His and mTDH-His using chromosomal DNA and pla
M ¼ Marker, lane 1 preTDH1/2-His CRM, lane 2 mTDH1/2-His CRM, lane 3 preTDH
control, NTC), lane 6 preTDH1/2-His SN, lane 7 mTDH1/2-His SN, lane 8 preTDH2-
NTC).detected. Functionality was demonstrated by hemolysis on
rabbit erythrocytes in hemolysis assays (see
Supplementary Fig. S4).
4. Conclusion
In this study, we describe the successful cell-free
expression of functional thermostable direct hemolysin
which is a major virulence factor of V. parahaemolyticus.smid DNA as a template for E-PCR. Left: SDS PAGE. Right: autoradiogram.
2-His CRM, lane 4 mTDH2-His CRM, lane 5 CRM as a control (no template
His SN, lane 9 mTDH2-His SN, lane 10 SN as a control (no template control,
S. Bechlars et al. / Toxicon 76 (2013) 132–142 141Since the mid of the 1990s the pandemic O3:K6 clone of
this pathogen has caused seafoodborne gastrointestinal
diseases in Asia and America, but is also now spreading to
European coasts and was detected in mussels in UK, Italy,
France and Spain. For identiﬁcation of pathogenic V. para-
haemolyticus strains assays for toxin detection are of in-
terest for food laboratories. The detection of the toxin
requires easy systems to produce the toxin for application
as reference materials or for use as antigen for the gener-
ation of antibodies. For functional studies or crystallo-
graphic investigations of the mature TDH variants it would
be preferable to express the protein individually instead of
a combined expression.
In this study we showed that TDH can be synthesized in
signiﬁcant amounts in the prokaryotic E. coli system. The
synthesis rate is nearly 100fold above the production ach-
ieved under optimized conditions with V. parahaemolyticus
(Nishibuchi et al., 1991). The synthesis can be easily per-
formed by using chromosomal DNA or by using plasmids as
a template for the two step E-PCR (Merk et al., 2003).
Additionally, no cloning steps are necessary for the
expression of toxins and therefore the whole expression
procedure is devoid of the generation of genetically
modiﬁed organisms. In our study, the parallel synthesis of
two closely related toxin variants (TDH1 and TDH2) was
achieved from one genomic DNA template, which is ad-
vantageous for the fast and efﬁcient generation of anti-
bodies. In conclusion, cell-free expression offers a time
saving and cost effective technology for the production of
biologically active toxins.
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